Correctol and Hyzaar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Correctol (bisacodyl) and Hyzaar (hydrochlorothiazide; losartan potassium). Common drug interactions include dysuria among females and cartilage injury among males.

The phase IV clinical study analyzes what interactions people have when they take Correctol and Hyzaar. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Correctol?

Correctol has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 152 Correctol users. Check the latest studies of Correctol.

What is Hyzaar?

Hyzaar has active ingredients of hydrochlorothiazide; losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 16,614 Hyzaar users. Check the latest studies of Hyzaar.



On Jul, 13, 2026

12 people who take Correctol and Hyzaar together, and have interactions are studied.

Correctol and Hyzaar drug interactions.

What are the common drug interactions of Correctol and Hyzaar, by gender? *:

female:

  1. Dysuria (painful or difficult urination)
  2. Herpes zoster
  3. Poor venous access
  4. Intestinal obstruction
  5. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  6. Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
  7. Dizziness
  8. Hypersensitivity
  9. Irritable bowel syndrome

male:

  1. Cartilage injury
  2. Deafness unilateral
  3. Poor venous access
  4. Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
  5. Stress
  6. Chronic kidney disease
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Renal failure (kidney dysfunction)
  10. Bladder disorder

What are the common drug interactions of Correctol and Hyzaar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

50-59:

  1. Dysuria (painful or difficult urination)
  2. Herpes zoster
  3. Poor venous access
  4. Intestinal obstruction
  5. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  6. Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
  7. Chronic kidney disease
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Renal failure (kidney dysfunction)

60+:

  1. Cartilage injury
  2. Deafness unilateral
  3. Poor venous access
  4. Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
  5. Stress
  6. Bladder disorder
  7. Blood cholesterol increased
  8. Cardiac fibrillation (uncontrolled muscle contraction of heart)
  9. Diarrhoea
  10. Hyperacusis (disorder in loudness perception)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 75.00%
  2. High Blood Cholesterol: 3 people, 25.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
  4. Thyroid Diseases: 1 person, 8.33%
  5. Renal Disorder (kidney disease): 1 person, 8.33%
  6. Nausea And Vomiting: 1 person, 8.33%
  7. Nausea (feeling of having an urge to vomit): 1 person, 8.33%
  8. Hypokalemia (low potassium): 1 person, 8.33%
  9. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 8.33%
  10. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Correctol and Hyzaar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Correctol and Hyzaar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Correctol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hyzaar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Correctol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hyzaar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bisacodyl and hydrochlorothiazide; losartan potassium (the active ingredients of Correctol and Hyzaar, respectively), and Correctol and Hyzaar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: